XML 52 R41.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT INFORMATION (Tables)
 9 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Schedule of segment revenues and profit
Segment revenues and profits for the three and nine months ended September 30, 2017 and 2016 were as follows:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(in millions)
2017
 
2016
 
2017
 
2016
Revenues:
 
 
 
 
 
 
 
Bausch + Lomb/International
$
1,254

 
$
1,243

 
$
3,645

 
$
3,666

Branded Rx
633

 
766

 
1,873

 
2,084

U.S. Diversified Products
332

 
470

 
1,043

 
1,521

 
$
2,219

 
$
2,479

 
$
6,561

 
$
7,271

 
 
 
 
 
 
 
 
Segment profits:
 
 
 
 
 
 
 
Bausch + Lomb/International
$
387

 
$
381

 
$
1,097

 
$
1,072

Branded Rx
357

 
484

 
1,024

 
1,078

U.S. Diversified Products
238

 
379

 
757

 
1,227

 
982

 
1,244

 
2,878

 
3,377

Corporate
(126
)
 
(185
)
 
(432
)
 
(525
)
Amortization of intangible assets
(657
)
 
(664
)
 
(1,915
)
 
(2,015
)
Goodwill impairments
(312
)
 
(1,049
)
 
(312
)
 
(1,049
)
Asset impairments
(406
)
 
(148
)
 
(629
)
 
(394
)
Restructuring and integration costs
(6
)
 
(20
)
 
(42
)
 
(78
)
Acquired in-process research and development costs
—

 
(31
)
 
(5
)
 
(34
)
Acquisition-related contingent consideration
238

 
(9
)
 
297

 
(18
)
Other income (expense), net
325

 
(1
)
 
584

 
20

Operating income (loss)
38

 
(863
)
 
424

 
(716
)
Interest income
3

 
3

 
9

 
6

Interest expense
(459
)
 
(470
)
 
(1,392
)
 
(1,369
)
Loss on extinguishment of debt
(1
)
 
—

 
(65
)
 
—

Foreign exchange and other
19

 
(2
)
 
87

 
4

Loss before recovery of income taxes
$
(400
)
 
$
(1,332
)
 
$
(937
)
 
$
(2,075
)
Schedule of total assets by segment
Total assets by segment were as follows:
(in millions)
September 30,
2017
 
December 31,
2016
Assets:
 
 
 
Bausch + Lomb/International
$
15,608

 
$
16,201

Branded Rx
18,455

 
21,143

U.S. Diversified Products
5,172

 
5,820

 
39,235

 
43,164

Corporate
739

 
365

Total assets
$
39,974

 
$
43,529